shi, y., Rogers, R., Vieira, K., Merhi, B., Osband, A., Bayliss, G., . . . Farmakiotis, D. (2020). 576. Half-dose Valganciclovir Prophylaxis is Safe and Cost-effective in CMV Seropositive Renal Transplant Recipients. Open Forum Infect Dis.
Citação norma Chicagoshi, yiyun, Ralph Rogers, Kendra Vieira, Basma Merhi, Adena Osband, George Bayliss, Reginald Gohh, Paul Morrissey, and Dimitrios Farmakiotis. "576. Half-dose Valganciclovir Prophylaxis Is Safe and Cost-effective in CMV Seropositive Renal Transplant Recipients." Open Forum Infect Dis 2020.
ציטוט MLAshi, yiyun, et al. "576. Half-dose Valganciclovir Prophylaxis Is Safe and Cost-effective in CMV Seropositive Renal Transplant Recipients." Open Forum Infect Dis 2020.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.